The latest progress in cellular immunotherapy for nasopharyngeal carcinoma

Recent progress in cellular immunotherapy for nasopharyngeal carcinoma

1. Biological cell immune technology is an emerging tumor treatment model with significant therapeutic effects. It is a new treatment method that uses autoimmune cells to treat cancer. It uses biotechnology and biological preparations to culture and expand the collected immune cells in vitro, and then inject them into the patient's body to stimulate and enhance the body's own immune function, effectively eliminate cancer cells, and thus achieve the purpose of treatment. This immune technology treats cancer with the breakthrough of restoring and regulating the immune system, innovating the traditional treatment direction of cancer, and becoming a new method of anti-cancer treatment. Biological cell treatment can cultivate some immune cells that have the ability to kill tumors.

2. Common treatments for nasopharyngeal carcinoma include radiotherapy, chemotherapy, and cellular immunotherapy.

Does nasopharyngeal carcinoma have a serious reaction to oral chemotherapy drugs?

The chemotherapy response to nasopharyngeal carcinoma may vary from person to person, but generally speaking there will be some effects. On the one hand, it may cause some gastrointestinal reactions, such as nausea and vomiting, and on the other hand, it may cause damage to the functions of organs such as the liver, kidneys, heart, and lungs.

After chemotherapy, pay attention to eating a high-protein diet, do not smoke, do not drink, do not eat spicy food, pay more attention to rest, do not overwork, and see a doctor in time if the condition changes or other discomfort occurs. Nasopharyngeal carcinoma is generally treated with radiotherapy.